Concepedia

Wendelien Zeijlemaker

WZ

11

Publications

941

Citations

11

H-Index

2013

Active since

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

Cancer Center Amsterdam

Ziekenhuisnetwerk Antwerpen Stuivenberg

University Hospital of Bern

Wendelien Zeijlemaker is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, hematology, and health sciences.

Top concepts

MedicineHematologyHealthOncologyImmunologyCell BiologyStem CellsCancer ResearchStem Cell ResearchPathology

Publications per year

2013–2020

11

Publications

11

Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia

Monique Terwijn, Wendelien Zeijlemaker, Angèle Kelder et al. · PLoS ONE · 2014 · 208 citations · Full text

CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia

Wendelien Zeijlemaker, Tim Grob, Rosa Meijer et al. · Leukemia · 2018 · 200 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +10

A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia

Wendelien Zeijlemaker, Angèle Kelder, Yvonne J.M Oussoren-Brockhoff et al. · Leukemia · 2015 · 121 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +13

Tumor heterogeneity makes AML a “moving target” for detection of residual disease

Wendelien Zeijlemaker, J.W. Gratama, Gerrit Jan Schuurhuis · Cytometry Part B Clinical Cytometry · 2013 · 89 citations

Oncologic Imaging, Pathology, Chemotherapy Resistant Subpopulation +18

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

Wendelien Zeijlemaker, Angèle Kelder, Yvonne J.M Oussoren-Brockhoff et al. · Leukemia · 2015 · 82 citations

Hematological Malignancy, Bone Marrow Failure, Mixed-phenotype Acute Leukemia +10

Rows per page

1–5 of 11